Cervical and vaginal secretions from 17 women infected with human immunodeficiency virus type 1 (HIV-1) were evaluated daily through the course of one menstrual cycle for HIV-1 DNA (21 -31 visits per woman). HIV-1 -infected cells were detected in 207 (46%) of 450 endocervical swabs and 74 (16%) of 449 vaginal swabs. There was considerable variability in the percentage of positive swabs from each woman, ranging from 4% to 100% of endocervical swabs and from 0 to 71% of vaginal swabs. In multivariate analyses, plasma HIV-1 RNA was significantly associated with shedding of HIV-1 -infected cells; each 1-unit increase in the log of plasma virus load was associated with a 5.6-fold increase in the odds of cervical shedding (95% confidence interval [CI], 2.1 -14.8) and a 3.9-fold increase in the odds of vaginal shedding (95% CI, 2.1 -7.2). There was no discernible pattern of genital tract shedding with phase of the menstrual cycle and no significant association with serum estradiol or progesterone levels.
With the continued rapid spread of human immunodeficiency topy, gonococcal cervicitis, candidiasis, cervical and vaginal inflammation, and vitamin A deficiency [3 -8] . virus type 1 (HIV-1) in most parts of the world, an understanding of factors that govern the transmission of HIV-1 remains
There are few data, however, regarding the frequency of cervicovaginal shedding within women over time and the of critical importance in designing intervention strategies. Heterosexual transmission accounts for the majority of HIV-1 inpossible effect of plasma virus load or menstrual cycle hormonal changes. We conducted a prospective study in which fection in adults, while mother-to-child transmission is the predominant mode of infection among children [1] . It is estimated cervical and vaginal secretions of 17 women were evaluated daily over the course of one menstrual cycle. Each woman that half of the children who acquire HIV-1 from their mothers become infected during delivery [2] . The principal determiwas enrolled at the onset of her menses and continued in daily follow-up, including weekends, until menses started nants of HIV-1 shedding in the female genital tract are likely to be important risk factors for both heterosexual and vertical again. Cervical and vaginal shedding of HIV-1 -infected cells was assessed in relation to plasma HIV-1 RNA level, phase transmission of HIV-1.
Cross-sectional studies of HIV-1 shedding in the female genof the menstrual cycle, serum estradiol and progesterone levels, and other factors. ital tract have shown HIV-1 -infected cells or free virus to be present in 30% -50% of cervical fluid samples and 10% -15% of vaginal fluid samples [3 -9] . These studies identified significant correlates of cervical and vaginal shedding, including Methods CD4 lymphocyte depletion, use of oral contraceptive pills, use Study design. HIV-1-infected women attending a municipal of depo medroxyprogesterone acetate, pregnancy, cervical ecsexually transmitted diseases (STD) clinic in Mombasa, Kenya, were invited to participate if they reported having menses at regular monthly intervals during the previous 1 year, if they had not used hormonal contraception or an intrauterine device in the previous Table 1 . Endocervical shedding of HIV-1 -infected cells throughout menstrual cycle.
Plasma
Detection of HIV-1 -infected cells in cervical secretions by day of menstrual cycle † HIV-1 RNA  CD4  HIV-1  Participant  copies/mL  cells/mL*  subtype  1  2  3  4  5  6  7  8  9  1 0  1 1  1 2  1 3  1 4   1 HIV-1 RNA, serum vitamin A, and CD4 lymphocyte count were Lenexa, KS); culture of Lactobacillus species (Ragosa agar; Difco Laboratories, Detroit) and assay of isolates for hydrogen peroxide measured at enrollment; a second CD4 cell count was done 3-4 weeks later. Participants were asked to abstain from sexual activity production [10] ; Gram's stain evaluation of bacterial vaginosis [11] ; count of polymorphonuclear leukocytes (PMNL) in three or to use condoms for all sexual encounters during the study period and to refrain from douching. nonadjacent 11000 fields of Gram's-stained vaginal fluid; and pH determination (ColorpHast pH 4.0-7.0 indicator strips; EMData and sample collection. At study enrollment, women were interviewed by use of a standardized questionnaire regarding deReagents, Gibbstown, NJ). Cervical secretions were collected for count of PMNL in three nonadjacent 11000 fields of Gram'smographic, medical, reproductive, and contraceptive histories. At daily follow-up visits, women were interviewed with a short stanstained cervical mucus; culture of Neisseria gonorrhoeae on Thayer-Martin media; and detection of Chlamydia trachomatis dardized questionnaire regarding sexual and douching activity in the previous 24 h. At enrollment, patients underwent general physiantigen (Microtrak II; Syva, San Jose, CA). Blood tests. The HIV-1-seropositive status of all participants cal examination, pelvic examination, and collection of genital tract samples for HIV-1 DNA analysis. Screening for STDs was done was confirmed with two EIAs (Detect; BioChem Immunosystems, Montreal, Canada; and Recombigen; Cambridge Biotech, Worcesat weekly intervals, always after samples for HIV-1 DNA analysis had been collected. All examinations were done by a single investiter, MA). Sera were tested for syphilis using rapid plasma reagin (Becton Dickinson, Cockeysville, MD) and Treponema pallidum gator (S.B.M.).
During daily examinations, vaginal secretions were collected for hemagglutination assay (Biotec, Suffolk, UK). CD4 lymphocytes were quantified in EDTA-anticoagulated whole blood by a manual HIV-1 DNA analysis by rolling a Dacron swab three full turns on the lateral vaginal wall with attention to avoiding pooled secretions. method (Cytosphere; Coulter, Hialeah, FL) [12] . Serum samples were assayed for estradiol and progesterone concentrations by cheEndocervical secretions were collected for HIV-1 DNA analysis by gently inserting a Dacron swab 1 cm into the cervical os and rotating miluminescent EIAs (Immulite; Diagnostic Products, Los Angeles). Vitamin A concentrations in light-protected serum samtwo full turns. The two swabs were put into separate dry cryovials, immediately placed on ice, and stored for up to 4 h until transfer to ples were determined by high-pressure liquid chromatography. Plasma was stored and shipped in liquid nitrogen to the University a 070ЊC freezer. For independent verification of cervical ectopy, a colposcopic photograph of each woman's cervix was taken at one of Washington, where HIV-1 RNA was quantified by bDNA assay (Quantiplex HIV-1 RNA 2.0; Chiron, Emeryville, CA) in EDTAtime point between days 20 and 25 of the cycle.
At weekly intervals, vaginal fluids were collected for wet mount anticoagulated plasma. 
Delwart et al. [13] . Proviral envelope sequences encompassing For purposes of inclusion in GEE analysis, variables that were detected in weekly screening tests were coded as present for 4 variable regions 1 -3 (V1 -V3) were compared with standard subtype reference strains (NIH AIDS Research and Reference days before and 4 days after the day of detection. These variables included microscopic detection of Candida species, culture of LacReagent Program), as well as representative Kenya envelope gene clones of known subtype [14] . Envelope sequences encomtobacillus species, cervical PMNL count ú30/high-power field, vaginal PMNL count ú5/high-power field, and vaginal Gram's passing C2 -C3 were analyzed in cases in which the subtype could not be unambiguously assigned on the basis of the V1 -stain score §7 (indicating bacterial vaginosis [11] ). T. vaginalis was coded as present for 4 days before detection and 1 week after V3 sequence.
single-dose treatment to allow for resolution of potential inflamGenital tract HIV-1 DNA assay. Cervical and vaginal swab mation. N. gonorrhoeae and cervical ectopy could not be included samples were shipped on dry ice to the University of Washington in GEE analyses because each condition was present in only 1 and stored at 070ЊC. Swabs were prepared and tested for HIV-1 woman, and both were shedding HIV-1-infected cells at every DNA by nested polymerase chain reaction (PCR) assays for the visit. highly conserved gag gene, as previously described [15] . This GEE models included all visits at which serum estradiol and method is sensitive to the detection of a single copy of HIV-1 progesterone were measured. Factors that may result in altered DNA [15] .
cervicovaginal mucosa or secretions were initially evaluated in Data analysis. Spearman's correlation coefficient was used to univariate models. A base model that included serum hormone evaluate univariate associations between frequency of genital HIVlevels and plasma HIV-1 RNA was then formed, and other 1 detection and plasma HIV-1 RNA levels or CD4 lymphocyte factors were added to this model one variable at a time. The count; the x 2 test was used to evaluate the association between added variable was retained in the final model if its P value cervical and vaginal HIV-1 DNA detection (SPSS Statistical Softwas £.10. ware, Chicago). Univariate and multivariate odds ratios (ORs) and confidence intervals (CIs) for correlates of cervical and vaginal HIV-1 DNA shedding were obtained with generalized estimating equation (GEE) analysis, using logistic regression models and an § HIV-1 subtype could not be determined using heteroduplex mobility assay.
x HIV-1 subtype from this woman was most closely related to subtype A outlier previously identified in Kenya (Q45) [14] .
duration of the menstrual cycle was 28 days (range, 22 -37).
Endocervical and vaginal shedding of HIV-1 -infected cells.
HIV-1 DNA was detected in 207 (46%) of 450 endocervical Fourteen women were enrolled on the first or second day of menses, 2 on the fourth, and 1 on the fifth. Eleven women swab samples. There was considerable variability in the percentage of positive cervical samples for a given woman, rangcompleted the study without missing an examination, while 6 women missed 1 or 2 visits each. One woman (participant 5)
ing from 4% to 100%. Each line of table 1 represents results from cervical swabs collected throughout the menstrual cycle was excused from examination the last 4 days of her menstrual cycle, as her cycle was very long and she had already underfor a given woman. The subjects are presented in order by the percentage of cervical swabs that had detectable HIV-1 DNA. gone 31 examinations.
Individual plasma HIV-1 RNA levels, CD4 lymphocyte Three groups were formed, based on low, intermittent, or high frequency of cervical shedding (HIV-1 DNA detected in counts, and HIV-1 subtypes are given in tables 1 and 2. The median plasma virus load was 5510 RNA copies/mL (range, õ25%, 48% -72%, and 93% -100% of samples, respectively). The log plasma HIV-1 RNA level was significantly correlated õ500 -251,000), and median CD4 lymphocyte count was 377/mL (range, 139 -566). Ten women had HIV-1 subtype with the percentage of cervical swabs that had detectable HIV-1 DNA (r Å .7, P Å .004). There was an inverse correlation A, 4 subtype C, and 2 subtype D; the subtype of virus from 1 woman could not be determined by the heteroduplex mobilbetween CD4 lymphocyte count and percentage of positive cervical swabs, but this was not statistically significant (r Å ity assay. No woman was receiving antiretroviral treatment. The median vitamin A level was 43 mg/dL (range, 24 -66); 0.3, P Å .3). There was no clustering of positive HIV-1 DNA results during the first 4 -6 days of the menstrual cycle, when 4 of 17 women (participants 1, 5, 10, and 15) had levels consistent with vitamin A deficiency (õ30 mg/dL [õ1.05 menstrual blood was present. HIV-1 DNA was detected in 74 (16%) of 449 vaginal mmol/L]) [16] .
The median frequency of unprotected sexual intercourse durswab samples. As with cervical shedding, there was great variability in the percentage of vaginal swabs that were posiing the study period was 3 (range, 0 -9), with no woman reporting more than two different partners. All STDs and other tive for a given subject. Five of 17 women had no positive vaginal swab, while the remainder had 4% to 71% of swabs genital tract conditions occurring during the study are summarized in %  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33 at both sites. HIV-1 subtype C was associated with significantly (30%) of 206 days on which endocervical HIV-1 DNA was increased odds of vaginal shedding relative to subtype A (OR, detected and on 13 (5%) of 243 days on which endocervical 3.9; 95% CI, 1.3 -11.8; P Å .02); if adjusted for plasma HIV-HIV-1 DNA was absent (P õ .001). The log plasma RNA 1 RNA level, the association was still positive but no longer level was significantly correlated with the percentage of significant (OR, 2.1; 95% CI, 0.7 -6.2; P Å .2). HIV-1 DNA -positive vaginal swabs (r Å .6, P Å .02). CD4
In multivariate analyses, each 1-unit increase in the log cell count was inversely correlated with frequency of vaginal plasma HIV-1 RNA concentration was associated with a 5.6-shedding (r Å 0.5, P Å .03).
fold increase in the odds of cervical shedding and a 3.9-fold Hormone levels and genital tract shedding throughout the increase in the odds of vaginal shedding. Neither serum estramenstrual cycle. Estradiol and progesterone levels were diol nor progesterone were significantly associated with cerviquantified in an average of 12 serum samples per woman cal or vaginal HIV-1 DNA detection, although vaginal shed-(range, 9 -17). Normal serum hormone profiles [17] and midding was less frequent with higher serum levels of estradiol. cycle urine luteinizing hormone peaks suggested that 16 of 17
Vitamin A deficiency was associated with a 2.4-fold increase women had ovulatory menstrual cycles (all but participant 17).
in the odds of vaginal shedding. Figure 1A shows the mean hormone profile for these 16 women, aligned on the day of each woman's luteinizing hormone peak (day 0). In figures 1B and 1C, the percentages of Discussion cervical and vaginal swabs with detectable HIV-1 DNA were calculated for each day of the menstrual cycle. There was no
In our evaluation of endocervical and vaginal fluid samples discernible pattern of shedding of HIV-1 -infected cells by day collected through the menstrual cycles of 17 women, the freor phase of the menstrual cycle. Also, as shown in tables 1 quency of shedding HIV-1 -infected cells in the genital tract and 2, the pattern of shedding for any given woman did not was highly variable among women. Endocervical and vaginal secretions were collected at daily intervals for 21 -31 visits per appear to vary with phase of cycle.
/ 9d52$$oc20
08-07-98 10:59:29 jinfas UC: J Infect necrotic ischemic endometrium rather than systemic blood ‡ This participant was treated with 3 weekly injections of benzathine penicillin during study. Syphilis was detected by rapid plasma reagin and Treponema [26, 29] .
pallidum hemagglutination tests.
The relationship between HIV-1 subtype and viral trans- § Infection was treated within 1 day of detection. missibility is currently poorly understood [30] . This potential x Hydrogen peroxide -producing Lactobacillus species. Ø Indicates bacterial vaginosis [11] .
association is complex to evaluate because it may be con-** Average count of polymorphonuclear leukocytes in three 11000 fields.
founded by differences in ecologic, sociobehavioral, and biologic cofactors. One important component of evaluating potential differences in transmissibility by HIV-1 subtype is to examine virus load in genital tract secretions. Our study included women with three HIV-1 subtypes: A, C, and D. woman, representing the most intensive evaluation of genital tract HIV-1 shedding to date. Each woman had HIV-1 -infected Subtype C was associated with increased odds of vaginal shedding in univariate analysis, but this association was no cells detected in genital secretions on at least 1 day during the menstrual cycle, but the percentage of positive swabs from longer significant after controlling for plasma virus load. An understanding of the relationship between HIV-1 subtype each woman ranged from 4% to 100% of endocervical and 0 to 71% of vaginal fluid samples.
and genital tract shedding requires additional studies with larger numbers of subjects and multiple viral subtypes reprePlasma HIV-1 RNA level was a highly significant predictor of both endocervical and vaginal shedding of HIV-1 -infected sented in the sample. Our study has shown that there is substantial variability in cells. Each 1-unit increase in the log plasma HIV-1 RNA level was associated with 5.6-fold -and 3.9-fold -increased odds of the frequency of endocervical and vaginal shedding of HIV-1 -infected cells among women and that the pattern of shedding shedding HIV-1 -infected cells in cervical and vaginal secretions, respectively. Plasma HIV-1 RNA concentration is eleis not substantially influenced by menstrual cycle hormonal changes. Plasma HIV-1 RNA level was the principal correlate vated in persons with advanced HIV-1 disease [18] , and our data suggest that this influences frequency of genital tract shedof HIV-1 -infected cells in both endocervical and vaginal fluids. It is currently unclear whether HIV-infected cells or free ding and, thereby, perhaps the risk of HIV-1 transmission. This hypothesis is corroborated by epidemiologic data showing that virions are most important in transmission of HIV-1, and thus whether HIV-1 DNA or RNA is a more relevant marker of HIV-1 is transmitted more frequently to sex partners of women with advanced HIV-1 disease and AIDS [19] . Vertical trans-''infectiousness'' in studies of genital tract shedding (Over- baugh J, et al., unpublished data). Because HIV-1 DNA and mission. Efforts to prevent both sexual and mother-to-child transmission of HIV-1 will be enhanced by an understanding RNA are detected during two closely linked stages of the viral replication cycle, both of which are required for productive of factors governing the presence and quantity of HIV-1 in cervicovaginal secretions and the identification of strategies to infection, evaluation of both markers is likely to be essential in determining the mechanism and correlates of HIV-1 transreduce such shedding.
/ 9d52$$oc20 08-07-98 10:59:29 jinfas UC: J Infect .05 * Models include all visits for which serum estradiol and progesterone were measured (endocervical models, n Å 189 visits; vaginal models, n Å 188 visits).
† Vaginal HIV-1 DNA was detected on only 1 of 24 days on which Trichomonas vaginalis was coded as present, thus, no estimate for T. vaginalis could be obtained.
‡ OR, odds ratio; CI, confidence interval. § Estradiol, per 367-pmol/L increase; progesterone, per 16-nmol/L increase; serum vitamin A õ1.05 mmol/L. x HIV-1 subtype was not determined for participant 13, resulting in exclusion of 13 visits from both endocervical and vaginal models. Two women had HIV-1 subtype D, but neither had detectable vaginal HIV-1 DNA at any visit, and thus no estimate for subtype D in relation to vaginal shedding could be obtained.
Ø Average count of polymorphonuclear leukocytes in three 11000 fields. ** Indicates bacterial vaginosis [11] .
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